ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Washington, DC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Washington, DC, USA:

Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers (GD-T2D)

Use Dapagliflozin 10 mg, Saxagliptin 5 mg, Metformin 500 mg treat type 2 diabetes patients with controlled cancers...

Active, not recruiting
Type 2 Diabetes
Drug: Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes
Drug: China Import (dapagliflozin) + China Import (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes

Phase 2, Phase 3

Han Xu, M.D., Ph.D., FAPCR, Medical Director,, IRB Chair

Rockville, Maryland, United States

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Active, not recruiting
Diabetes
Type2diabetes
Device: Endogenex Treatment
Device: Sham Procedure
Endogenex

Baltimore, Maryland, United States and 43 other locations

Status recently updated

the efficacy and safety of icovamenib in participants with Type 2 Diabetes who are not achieving glycemic targets despite antihyperglycemic ...

Enrolling
Active, not recruiting
Type 2 Diabetes
Drug: Placebo
Drug: icovamenib 100mg

Phase 2

Biomea Fusion

Manassas, Virginia, United States of America and 17 other locations

Locations recently updated

of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI), or with type ...

Enrolling
Type 2 Diabetes (T2D)
Type 1 Diabetes (T1D)
Device: MODI Algorithm
DreaMed Diabetes

Baltimore, Maryland, United States and 5 other locations

This study is a Phase 2 clinical trial to evaluate the efficacy, safety, and tolerability of HM15275 in subjects with type 2 diabetes mellit...

Enrolling
Type 2 Diabetes Mellitus
T2DM
Drug: HM15275
Drug: Placebo of HM15275

Phase 2

Hanmi Pharmaceutical
Hanmi Pharmaceutical

Manassas, Virginia, United States of America and 14 other locations

This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Drug: icovamenib 100 mg
Drug: Placebo

Phase 2

Biomea Fusion

Burke, Virginia, United States and 16 other locations

African American Veterans with albuminuric stage 2 and 3 chronic diabetic kidney disease (DKD), using Empagliflozin or Finerenone or combina...

Begins enrollment this month
Diabetic Kidney Disease
Drug: Empagliflozin 10 MG
Drug: Finerenone 10 MG

Phase 4

Washington D.C. Veterans Affairs Medical Center

Washington D.C., District of Columbia, United States

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Baltimore, Maryland, United States and 24 other locations

The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to pl...

Not yet enrolling
Diabetes Mellitus, Type 2
Obesity or Overweight
Drug: AZD6234
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Oxon Hill, Maryland, United States and 217 other locations

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...

Enrolling
Type II Diabetes Mellitus
Other: Placebo
Drug: CX11

Phase 2

Corxel Pharmaceuticals

Silver Spring, Maryland, United States and 47 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems